| ||||||||||||||||||||||
The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline Supplementary Data Files in this Data Supplement:
Hum. Reprod. Mavranezouli and on behalf of the LARC Guideline Development Group
23: 1338
Supplementary Data
| ||||||||||||||||||||||